Anders Malm appointed as Managing Director at Ecron Acunova

Anders Malm

Anders Malm has been appointed as the Managing Director of Ecron Acunova, based in Frankfurt, Germany. Malm assumes the responsibility for operations of Europe and North America. He joins a management team consisting of Dr Klaus Wiedey, Managing Director of EA Germany and Chief Executive Officer Europe and Klemens Schuette, Managing Director of New Business Opportunities.

Malm joined Ecron Acunova in 2012 as Managing Director of Ecron Acunova A/S in Denmark with responsibility for the Nordic region. With his experience in managing an Oncology CRO in the US, he was made responsible for North American operation as Chief Executive Officer of Acunova Life Sciences, Princeton, NJ. With a M Sc from Cornell University and a MBA from Sweden, Anders Malm brings 25 years of business experience, with 15 years in the CRO sector on both sides of Atlantic.

Malm said, “Ecron Acunova is a CRO with rich experience and potential. With a highly trained staff in three continents Ecron Acunova has a knowledge base which is unique for a CRO of our size. The company has a global reach, while at the same time we are small enough to take care of clients on a local basis. We will continue to serve existing clients and build close relations with biotech and smaller pharmaceutical companies for global as well as local services. It is a pleasure and privilege for me to be part of the leadership team of Ecron Acunova.” Speaking on the appointment, DA Prasanna, Chairman, Ecron Acunova CRO (EA) said, “Malm brings extensive professional experience in clinical research services and network of customer relationship in Europe and the US. With his experience, he will grow and transform Ecron Acunova services to effectively meet the changing needs of sponsors.”

EP News Bureau – Mumbai